TNF and infection: Thus, additional research is needed to define the best strategy to minimise the risk ofaMI in patients with CIA after using TNFα blockers, including IGRAs, but also the roleand clinical utility of the PPD-Booster phenomenon in predicting the development ofactive infection by M. tuberculosis, especially in countries with highprevalence of the disease, such as Brazil.